跳至主要内容
临床试验/NL-OMON48828
NL-OMON48828已完成不适用

Predicting Treatment Resistance in Schizophrenia - TREVOS

Academisch Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • For patients:
  • - First episode psychosis
  • - Age 18-35 years old;For healthy contols:
  • - Age 18-35 years old

排除标准

  • - Antipsychotic use longer than one year
  • - Dependence on other substances of abuse than nicotine or cannabis
  • - Use of amphetamine, cocaine or medication for ADHD (attention deficit hyperactivity disorder), since these drugs influence the dopamine system
  • - Neurological disorder (e.g. epilepsy) or evidence of brain damage
  • - Inability to provide informed consent;In addition to the exclusion criteria mentioned above, healthy control subjects are not allowed to have any kind of psychiatric disorder;Exclusion criteria directly related to MRI scanning:
  • - Contra-indications for MRI (including pacemaker, ferromagnetic implants, claustrophobia)
  • - Pregnancy;Exclusion criteria directly related to PET/CT scanning (for subgroup of 40 patients):
  • - Participation in a scientific examination where radiation was used, in the last year.
  • - Positive urine drug screen on the day of the PET/CT scan. Participants will be tested on cannabis, amphetamine, XTC, cocaine and opiates. Only recent cannabis use will be accepted.
  • - In women: positive pregnancy test on the day of the PET/CT scan and lactation.

研究者

相似试验